Republicans jam Price nomination through Finance committee despite new revelations on questionable stock trades
Wall Street Journal: “Rep. Tom Price Got Privileged, Discounted Offer on Biomedical Stock, Company Says”
WASHINGTON, D.C. – Today, U. S. Senator Patty Murray (D-WA) issued the following statement on Finance Committee Republicans’ decision to break longstanding Committee rules and advance the nomination of Congressman Tom Price despite serious, outstanding concerns about the medical stock trades he made while legislating on health care policy.
“It is appalling that this morning, Senate Republicans chose to overlook serious concerns about Congressman Price’s questionable stock trades, break longstanding rules, and hold a secret, closed-door vote to force his nomination through committee. Senate Republicans appear to have completely forgotten that here in the Senate, we have a responsibility to our constituents to thoroughly evaluate President Trump’s Cabinet nominees—not rubber-stamp them or cut corners to jam them through.”